Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AQUIPTA 10 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/AQUIPTA 10 MG COMPRIMIDOS

Approved

STANDARD

AQUIPTA 10 MG COMPRIMIDOS

Abbvie Deutschland Gmbh & Co. Kg🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 27, 2023
Approval ID: 2580c63d53b98b4a
Company: Abbvie Deutschland Gmbh & Co. Kg
Type: Standard

Approval Details

Approval Id: 2580c63d53b98b4a
Drug Cima Aemps Name: AQUIPTA 10 MG COMPRIMIDOS
Register Number: 1231750001
Holder Company Name: Abbvie Deutschland Gmbh & Co. Kg
Marketing Company Name: Abbvie Spain, S.L.U.
Holder Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg
Authorization Date: 2023-10-27
Dosage Form: COMPRIMIDO
Dose: 10 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Abbvie Deutschland Gmbh & Co. Kg
Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg

Company Information

Pharmaceutical Company Name: AbbVie Deutschland GmbH & Co. KG
Country Name: Germany
City Name: ludwigshafen am rhein,rheinland-pfalz,country_de
Address: Knollstr. 50
Website: http://www.abbvie.de

Active Ingredients

ATOGEPANT MONOHIDRATO

10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 27, 2023

Approval ID

2580c63d53b98b4a

Type

Standard

Back to CIMA-AEMPS Approvals